Kimberly-Clark Closes $40B Kenvue Deal, Books $3.1B Integration Charge
KMB sits 18% above its 52-week low of $92.42 on elevated volume (2.3× avg).
Summary
Kimberly-Clark completed its $40 billion acquisition of Kenvue, issuing about 281.1 million shares plus $3.50 cash per Kenvue share, and disclosed a $3.1 billion integration program with roughly $2.1 billion of targeted run-rate synergies.
Key Events · M&A and Partnerships · KMB
-
Kenvue Acquisition Closes
Kenvue shareholders received $3.50 in cash and 0.14625 KMB shares per share; Kenvue stock ceased trading on the NYSE at the open on November 2, 2026.
-
$3.1B Integration Charge Planned
The Kenvue Integration Program carries roughly $3.1 billion of cumulative pre-tax charges through December 31, 2029 ($2.5 billion cash, $0.6 billion non-cash) plus about $1.4 billion of capital spending.
-
281.1M Shares Issued as Consideration
Kimberly-Clark delivered or is obligated to deliver approximately 281,060,840 shares of common stock in the aggregate for outstanding Kenvue shares.
-
Synergy Target Reaffirmed at $2.1B
Management reiterates roughly $2.1 billion of run-rate synergies: about $1.9 billion of cost savings within three years and about $500 million of revenue synergy profit within four years, partly offset by $300 million of reinvestment.
Analysis · KMB · Manufacturing
With the $40 billion Kenvue acquisition now closed, Kimberly-Clark becomes a combined consumer health and personal care company with 10 billion-dollar brands. The filing puts hard numbers on the cost of getting there: roughly $3.1 billion of cumulative pre-tax charges through 2029 ($2.5 billion cash, $0.6 billion non-cash) plus about $1.4 billion of capital spending, against reaffirmed run-rate synergies of roughly $2.1 billion. Kimberly-Clark also issued about 281.1 million shares as stock consideration, so the share count is materially larger and future per-share figures will be spread over a bigger base. Integration execution and whether the synergy targets land are now the main drivers of the investment case.
How filings like this one have moved
In the 30 days to Nov 2, 2026, 49.5% of the 190 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, KMB was trading at $109.10 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $35.9B. The 52-week trading range was $92.42 to $123.09. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.